secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001641172-25-013021
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity receives Nasdaq delisting notice; equity of $1.44M below $2.5M minimum
--------------------------------------------------------------------------------

- Stockholders' equity was $1,439,404 as of March 31, 2025, well below the $2,500,000 minimum.
- Company must submit a compliance plan by July 11, 2025 (45 days) to regain compliance.
- If plan accepted, Nasdaq may grant up to 180-day extension from May 27, 2025.
- Trading continues on Nasdaq Capital Market under BIAF and BIAFW symbols pending resolution.
- This notice is separate from prior bid price deficiency notice received February 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000164117225013021/0001641172-25-013021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000164117225013021/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer